Indication

10011762

1 clinical trial

1 product

Clinical trial

A Phase IIa, Randomized, Placebo-controlled, Double-blind, Cross-over Study to Evaluate Safety and Efficacy of Subcutaneous Administration of Anakinra in Patients With Cystic Fibrosis

Status: Recruiting, Estimated PCD: 2024-12-01

Product